UBS Group’s Anebulo Pharmaceuticals ANEB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $132 | Buy |
92
+91
| +9,100% | +$131 | ﹤0.01% | 8647 |
|
|
2025
Q1 | $1 | Sell |
1
-24
| -96% | -$24 | ﹤0.01% | 8839 |
|
|
2024
Q4 | $42 | Sell |
25
-738
| -97% | -$1.24K | ﹤0.01% | 8474 |
|
|
2024
Q3 | $1.47K | Buy |
+763
| New | +$1.47K | ﹤0.01% | 7414 |
|
|
2024
Q2 | – | Sell |
-144
| Closed | -$413 | – | 8307 |
|
|
2024
Q1 | $413 | Buy |
+144
| New | +$413 | ﹤0.01% | 7402 |
|
|
2023
Q1 | – | Sell |
-1,696
| Closed | -$4.1K | – | 8449 |
|
|
2022
Q4 | $4.1K | Sell |
1,696
-1,085
| -39% | -$2.63K | ﹤0.01% | 8187 |
|
|
2022
Q3 | $8K | Sell |
2,781
-128
| -4% | -$368 | ﹤0.01% | 7582 |
|
|
2022
Q2 | $15K | Buy |
2,909
+753
| +35% | +$3.88K | ﹤0.01% | 6237 |
|
|
2022
Q1 | $15K | Buy |
2,156
+1,576
| +272% | +$11K | ﹤0.01% | 6769 |
|
|
2021
Q4 | $4K | Sell |
580
-268
| -32% | -$1.85K | ﹤0.01% | 8370 |
|
|
2021
Q3 | $6K | Buy |
848
+614
| +262% | +$4.34K | ﹤0.01% | 7254 |
|
|
2021
Q2 | $2K | Buy |
+234
| New | +$2K | ﹤0.01% | 7812 |
|